… of severe COVID-19 and the existing data behind various immunomodulatory strategies, and
… A challenge to antiviral therapy for COVID-19 is that patients with severe disease tend to …

… To the Editor: As the coronavirus disease 2019 (COVID-19) pandemic has rapidly spread …
receiving immunomodulatory therapies to severe acute respiratory syndrome coronavirus 2 (…

… targets for COVID-19. In this review, we summarize the immune characteristics of COVID-19
and … Immunomodulators are substances that affect immune system function, representing a …

… in the GREECO-19 study as a quite benign therapy for COVID-19 patients with no renal or
… myocardial infarction [15], and now for COVID-19, colchicine appears to be much more than …

… have anti-inflammatory, immunomodulatory, bronchodilatory, and antiviral … COVID-19 is
discussed. A discussion on possible side effects associated with EOs as well as anti-corona virus …

… modifying therapies (DMTs) for multiple sclerosis (MS) have variable immunomodulatory …
We aimed to determine the impact of DMTs on antibody response to COVID-19 vaccination …

… early immune response to COVID-19 that causes severe … therapy in severe COVID-19 cases.
Such immunotherapies based on inflammatory cytokine neutralization, immunomodulation, …

… their clinical efficacy remains to be established [19]. A concerted effort is … COVID-19,
emphasizing the number of drug combinations used in a given time in patients with severe COVID-19…

… on the use of immunomodulatory therapies in COVID-19. … on the use of immunomodulatory
therapies in COVID-19.62 … , the need for RCT with combination therapy (GC +anti-cytokines) …

… of inflammatory response associated with severe COVID-19 infection after incorporating a
… We hypothesized immunomodulation using the LMOD in patients with severe COVID-19 will …